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Abstract We investigated several hsp70/hsc70 interacting 
proteins and established by two independent techniques that 
hsp40 and Hop/p60 specifically interact with the 257 residue 
carboxy-terminal domain of hsp70 while Hap-46 and Hip/p48 
bind the 383 residue amino-terminal ATP binding domain. Hap-
46 and Hip/p48 competed for binding to hsc70, while Hap-46 had 
no effect on the binding of either Hop/p60 or hsp40 to hsc70. 
Hap-46 inhibited the refolding of thermally denatured firefly 
luciferase in an hsc70 and hsp40 dependent assay, and this effect 
was largely compensated by Hop/p60. These interacting proteins 
thus appear to cooperate in affecting the chaperoning activity of 
hsp70/hsc70. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The processes by which polypeptides and complex protein 
structures attain their native and biologically active conforma-
tions are of major importance in the field of protein biochem-
istry. Although such folding may occur spontaneously, it is in 
many cases assisted by proteins with chaperoning activity. 
Heat shock proteins of the 70 kDa protein family are certainly 
major chaperones involved in such ATP dependent folding 
reactions in eukaryotic cells (reviews: [1-3]), most notably 
the constitutively expressed heat shock cognate form hsc70. 
They have a distinct domain structure with an amino-termi-
nally located ATP binding domain and a carboxy-terminal 
domain that has affinity for misfolded or aberrant proteins 
and polypeptides (Fig. 1). 
Although hsp70/hsc70 by itself may exert some protective 
effects on denatured or misfolded proteins in that it is able to 
bind to them, it normally acts in concert with other cellular 
components which themselves associate with hsc70. In this 
respect, hsp40 and other members of the DnaJ-like protein 
family are of prime importance as cochaperones [4]. Recently, 
other hsp70/hsc70 interacting proteins have been identified: 
Hip/p48 was obtained as 'hsc70 interacting protein' and has 
an apparent molecular weight of 48 kDa [5,6]. Hop/p60 has 
been defined as 'hsp70/hsp90 organizing protein' [7] and was 
first described as a transformation sensitive human protein [8] 
and as the stress related protein p60 [9] with a molecular 
weight of roughly 60 kDa. Hap-46 is the acronym for 
'hsp70/hsc70 associating protein'; it was originally identified 
as the nuclear receptor associating protein RAP46 [10] of 
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apparent molecular weight 46 kDa. This protein has now 
been found to directly associate with hsp70 and several other 
members of the 70 kDa heat shock protein family [11]. Inter-
action occurs with the amino-terminal ATP binding domain 
of hsc70 [11], similar to that of Hip/p48 [5]. 
In the present investigation we further studied the binding 
of these proteins to hsp70/hsc70 and specific fragments thereof 
by use of in vitro assays and in vivo in yeast. We also exam-
ined the combined effects of these proteins in a protein refold-
ing system using thermally denatured firefly luciferase as mod-
el protein. 
2. Materials and methods 
2.1. Expression of tagged proteins 
The fusion protein of glutathione S-transferase (GST) with Hap-46 
and His tagged human hsp40 were as before [10-12]. His tagged frag-
ments of human hsp70 [13] were generated by PCR. For fragments 
Ni-hsp70 (codons 1-187), N2-hsp70 (188-383), and C-hsp70 (384-
640) primer pairs 5'-aattggatccgcatggccaaagccg-375'-aattaagctttctgtc-
caggccgta-3 ', 5 '-aattggatccggcctggacagaacg-3 75 '-aattaagcttgctccccat-
caggat-3', and 5'-aattggatccgggacaagtccgaga-375'-aattaagcttggcccc-
taatctacc-3' were used. AH sequences were verified and cloned into 
BamHl/Hindlll sites of pQE-30 and pQE-32 (Qiagen), resulting in 
plasmids pQE-32-Ni-hsp70, pQE-30-N2-hsp70 and pQE-30-C-hsp70. 
Expression in E. coli JM109 and purification was as before [11]. Ami-
no-terminally His tagged Hip/p48 and carboxy-terminally His tagged 
human Hop/p60 were expressed from plasmids pET-28a-Hip and 
pET-28a-Hop, respectively, in Escherichia coli BL21(DE3) [5] and 
purified on Talon resin (Clontech); after extensive washing with 1% 
Triton X-100, elution was with 100 mM imidazole. 
2.2. In vitro protein interaction experiments 
Proteins were analyzed by standard 10% or 12% SDS-PAGE and 
transferred to Immobilon-P membranes (Millipore) as before [10]. 
Hsc70 was detected by antibody N27F3-4 (Stressgen) and His tagged 
hsp70 fragments by antibody MRGSHis (Qiagen). Incubation with per-
oxidase conjugated second antibodies and detection with ECL (Amer-
sham) were by standard procedures. 
Far-Western blotting was as described [14] with the GST and hsp40 
specific antibodies Z-5 and C-20 (Santa Cruz) and Hop/p60 specific 
antibody SRA-1500 (Stressgen). 
Co-immunoprecipitations of bovine hsc70 (Stressgen) were carried 
out as before [11] with the above antibodies and Hip/p48 specific 
antiserum R-19 (Santa Cruz). 
2.3. Yeast two hybrid experiments 
Plasmids pGBT-Hsc70 and pGBT-N-Hsc70 containing codons 1-
646 and 1—383 of rat hsc70 were as described [11]. The above plasmids 
pQE-30-N2-hsp70 and pQE-30-C-hsp70 were cut with EcoRl and 
Hindlll, and PQE-32-Ni-hsp70 with BamHl and Hindlll. The respec-
tive hsp70 cDNA fragments were converted at their 3'-ends into blunt 
ends by standard techniques [15] and cloned into EcoRl/Smal or 
BamHl/Pstl sites of pGBT9 in frame with GAL4BD [16], with the 
Pstl site converted into blunt ends. This resulted in plasmids pGBT-
Ni-hsp70, pGBT-N2-hsp70, and pGBT-C-hsp70, respectively. 
Human Hip/p48 (codons 1-369) and Hop/p60 (only codons 1^ 146) 
cDNAs were ligated into the Smal site of pGAD424 [16] in frame 
with GAL4AD as described before for Hap-46 [11]. Human hsp40 
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Fig. 1. Domain structure of hsp70 and hsc70. Human hsp70 used 
here contains a total of 640 amino acids, while bovine hsc70 is of 
646 residues. Both have the same domain structure. 
cDNA was cloned into EcoKIIPstI sites of pGAD424. This resulted in 
plasmids pGAD-Hip, pGAD-Hop and pGAD-hsp40. 
Cells of strain HF7c (Clontech) were cotransformed as before [11] 
with plasmids pGAD-RAP, pGAD-Hip, pGAD-Hop and pGAD-
hsp40 and either pGBT-Hsc70, pGBT-N-Hsc70, pGBT-Ni-hsp70, 
pGBT-N2-hsp70, pGBT-C-hsp70 or pGBT9. Growth on plates in 
medium lacking His, Leu and Trp was scored after 5 days at 30°C. 
3. Results 
3.1. In vitro protein interactions 
To investigate the interaction of hsp40, Hap-46, Hip/p48, 
and Hop/p60 with either complete hsc70 or domains of hsp70 
we used far-Western blotting. Specific fragments of human 
hsp70 were bacterially expressed as His tagged polypeptides, 
purified, and run together with full length bovine hsc70 on 
SDS polyacrylamide gels. After blotting, proteins were rena-
tured on the membrane using a standard protocol [14] and 
membranes were then incubated with the above proteins. In-
teractions were detected by use of specific antisera directed 
against these interacting proteins. As Hap-46 and Hip/p48 
are known to interact with the amino-terminal 44 kDa ATP 
binding domain of hsc70 [5,11], we wondered whether hsp40 
and Hop/p60 also bind to this domain. However, Fig. 2 shows 
that both proteins rather interact with the 257 amino acid 
carboxy-terminal portion of hsp70. The same result was ob-
tained when we used co-immunoprecipitation with antisera 
specific for hsp40 and Hop/p60: the carboxy-terminal (resi-
dues 384-640), but not the amino-terminal (residues 1-383) 
domain of hsc70 was specifically retained (data not shown). 
According to X-ray studies, the ATP binding domain of 
hsp70s and several other ATP binding proteins consists 
mainly of two subdomains N! and N2 (cf. Fig. 1) separated 
by a deep cleft [17-19]. We therefore also checked constructs 
equivalent to these subdomains for interactions, i.e. polypep-
tides containing amino acids 1-187 and 188-383 of human 
hsp70. The experiments of Fig. 2 show that Hap-46 indeed 
binds to both fragments, albeit less avidly than to the entire 
ATP binding domain or to full length hsp70. This may sug-
gest that Hap-46 upon binding possibly bridges the cleft be-
tween these hsp70 subdomains. As expected from the above 
results, both Hsp40 and Hop/p60 did not bind to subdomains 
Ni and N2 (Fig. 2). 
Next we were interested in finding out whether some of the 
hsc70 interacting proteins hsp40, Hap-46, Hip/p48, and Hop/ 
p60 might interfere with each other's binding to hsc70. We 
used immunoprecipitation with antibodies specific for the re-
spective proteins and determined by Western blotting the rel-
ative amounts of hsc70 coprecipitated in the presence and 
absence of Hap-46. We found that Hap-46 competes for bind-
ing of Hip/p48 to hsc70, as one might expect for proteins 
which both interact with the ATP binding domain (Fig. 
3A). The amount of hsc70 retained on the Hip/p48 specific 
Fig. 2. Far-Western blots of hsp70/hsc70 with interacting proteins. Bovine hsc70 and the 44 kDa chymotryptic fragment thereof (N-Hsc70) 
were used. His tagged fragments Ni-Hsp70, N2-Hsp70, and C-Hsp70 are described in Section 2 and have apparent molecular weights of 25, 26, 
and 33 kDa, respectively, in SDS-PAGE. After electrophoresis (roughly 2 u.g each), these proteins were blotted and renatured [14]. Blots were 
incubated with His tagged hsp40 and Hop/p60 or GST-Hap-46 (50 u,g/ml each), as indicated, followed by specific antibodies, as described in 
Section 2. Only relevant portions of blots are depicted. 
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Fig. 3. Co-immunoprecipitation of hsc70 with interacting proteins. A: Bovine hsc70 (5 ug) was incubated for 16 h in the cold with hsp40, Hip/ 
p48, or Hop/p60 (10 ug each) either in the presence or absence of Hap-46 (10 ug), as indicated, and the specific antibodies against hsp40, Hip/ 
p48, or Hop/p60 (see Section 2), respectively, as well as protein G-Sepharose (Sigma); total volume 150 ul. ATP (5 mM) was included in each 
experiment. Analysis was by SDS-PAGE and immunoblotting with hsc70 specific antibody N27F3-4. B: Bovine hsc70 was similarly incubated 
with Hop/p60 and the Hop/p60 specific antibody in the presence or absence of hsp40 (10 ug each). 
matrix was decreased 2-3-fold by Hap-46. On the other hand, 
Hap-46 showed no effect on the binding of hsp40 or Hop/p60 
to hsc70 (Fig. 3A). Interestingly, hsp40 and Hop/p60 did not 
affect each other's binding to hsc70 with either Hop/p60 spe-
cifically bound to the matrix (Fig. 3B) or hsp40 bound corre-
spondingly (data not shown). 
3.2. Protein interactions in yeast cells 
To ascertain whether the above described in vitro protein 
associations pertain to interactions within living cells, we 
turned to the yeast two hybrid system [16]. As outlined in 
Fig. 4, the cDNAs for hsp40, Hap-46, Hip/p48, and Hop/ 
p60 were fused to the activating domain of the transcriptional 
activator protein GAL4 and tested against relevant constructs 
of mammalian hsp70/hsc70 fused to the DNA binding domain 
of GAL4. If protein associations occur, they will stimulate 
transcriptional activation of GAL4 responsive genes by put-
ting both GAL4 domains in juxtaposition. In the cell strain 
HF7c used in our experiments, the yeast HIS3 gene will then 
be turned on, resulting in growth in minimal medium. 
As shown in Fig. 4 (lines 2 and 4), Hap-46 associated with 
the ATP binding domain of hsc70 and was now found to 
mainly interact with subdomain N2 of the hsp70 ATP binding 
domain (residues 188-383). While Hip/p48 readily interacted 
in this assay system with the complete ATP binding domain 
(Fig. 4, line 2), it rather appeared to require both subdomains 
Ni (residues 1-187) and N2 (residues 188-383) for interaction. 
On the other hand, both Hop/p60 and hsp40 (Fig. 4, lines 1 
and 5) associated only with full length hsp70/hsc70 and with 
the carboxy-terminal domain (residues 384-640). Control ex-
periments showed that the DNA binding domain (BD) of 
GAL4 by itself does not interact with the activating domain 
(AD) fused to the various proteins (Fig. 4, line 6). The reverse 
control, GAL4AD tested against the GAL4BD-hsc70 con-
structs, was also negative (data not shown). 
3.3. Effects on refolding of heat denatured lucifer ase 
An important question relates to the effects of these inter-
acting proteins on the chaperoning activity of hsp70/hsc70. To 
this end we used thermally denatured firefly luciferase as a 
model protein and a published refolding system that depends 
on hsc70, hsp40, ATP, and a minimal amount of reticulocyte 
lysate [12]. We had previously found that Hap-46 efficiently 
inhibits reactivation of the denatured enzyme in a dose de-
pendent manner [11]. We now observed that the addition of 
Hip/p48 to this system interfered only slightly with the inhib-
ition caused by Hap-46 (Fig. 5, column 4) and did not affect 
the level of reactivation if added by itself (column 3). Inter-
estingly, Hop/p60 on its own significantly inhibited refolding 
(Fig. 5, column 5) and this inhibition was again not abolished 
Hsp70/hsc70 fusion proteins 
! GAL4BD 
1-147 
I GAL4BD 
1-147 
1 GAL4BD 
1-147 
| GAL4BD 
1-147 
I GAL4BD 
hsc70 
1-646 
N-hsc70 I 
1-383 
N,-hsp70j 
1-187 
N2-hsp70 | 
188-383 
C-hsp70 
GAL4BD 
1-147 
GAL4AD fused to 
Hsp40 Hap-46 Hip/p48 Hop/p60 
+ 
Fig. 4. In vivo interaction of hsp70/hsc70 with associating proteins. Constructs used in the yeast two hybrid system are described in Section 2. 
Growth in deficient medium was scored. 
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Hap-46 - + - + + - + 
Hip/p48 - - + + - - + + 
Hop/p60 - - - - + + + + -
Geldanamycin + 
Fig. 5. Reactivation of denatured luciferase. Firefly luciferase (Sig-
ma) was thermally denatured and reactivated as before [11,12] with 
purified hsc70 and hsp40 and 20-fold diluted, untreated rabbit retic-
ulocyte lysate (Promega). In controls without further additions, set 
here as 100%, reactivation levels were roughly 40%. Other assays 
contained 10 |iM concentrations of proteins, as indicated, or 40 |iM 
geldanamycin. Routinely, experiments were in triplicate. The average 
of three independent experiments is shown with error bars indicat-
ing standard deviations. 
by Hip/p48 (Fig. 5, column 7). By contrast, Hop/p60 was able 
to compensate the inhibitory action of Hap-46 on luciferase 
reactivation by roughly 50% (Fig. 5, column 6). Further ad-
dition of Hip/p48, however, did not further improve the re-
folding efficiency (Fig. 5, column 8). 
As hsp40 is an essential component of this refolding system 
[11,12] we wondered whether the inhibitory effect of Hap-46 
could be compensated by extra amounts of hsp40. However, 
this was not so in assays in which we added up to twice the 
amount of hsp40 as in the experiments of Fig. 5 (data not 
shown). 
We also asked whether hsp90 is involved in this refolding 
system as this heat shock protein is certainly contained in the 
reticulocyte lysate used in our experiments. We employed the 
hsp90 specific inhibitor geldanamycin [20,21] but did not ob-
serve any effect of this drug on the refolding of heat denatured 
luciferase (Fig. 5, column 9). 
4. Discussion 
The 274 amino acid protein Hap-46 of apparent molecular 
weight 46 kDa was originally detected as a steroid hormone 
receptor associating factor [10]. Recently it was observed to 
directly interact with hsc70 and selected members of the hsp70 
family while the association with nuclear receptors and a var-
iety of other cellular regulators rather depends on hsp70s as 
mediators of interaction [11]. In the presence of ATP, Hap-46 
dramatically reduced the association of several unrelated, but 
misfolded proteins to hsc70 and significantly inhibited the 
refolding of thermally denatured luciferase [11]. A related 
protein of mouse origin, called BAG-1, has also been obtained 
[22]; it contains only 219 amino acids and is of roughly 27 
kDa size [23]. Despite significant divergence in the amino-ter-
minal region, this protein also interacts with hsp70 family 
members and similarly affects their chaperone function [24]. 
We now suggest the introduction of a uniform nomenclature 
and propose that BAG-1 should be called Hap-27. However, 
it appears possible that still other related polypeptides exist 
which nevertheless may serve somewhat divergent cellular 
functions. 
We previously found that Hap-46 specifically interacts with 
the ATP binding domain of hsc70 [11]; so does Hip/p48 [5]. 
We now show that Hap-46 significantly competes with Hip/ 
p48 for binding to hsc70 (cf. Fig. 3A). Nevertheless, Hap-46 
and Hip/p48 are very different proteins, both in amino acid 
sequence and in structural organization. While Hap-46 does 
not self-associate [11], Hip/p48 is a homo-oligomer [25]. On 
the other hand, Hip/p48 and Hop/p60 do contain some se-
quence similarities, in particular tetratricopeptide repeats 
which are thought to be involved in protein-protein interac-
tions [2]. 
In the present study we further used defined fragments of 
hsp70/hsc70 for interaction experiments. Employing the far-
Western technique we observed that Hap-46 readily binds to 
both subdomains Nj (residues 1-187) and N2 (residues 188-
383) of the ATP binding domain (Fig. 2). However, in intact 
yeast cells we saw interaction only with subdomain N2 (cf. 
Fig. 4). Although the yeast two hybrid system is known for 
its tendency to produce false positives [26], we suspect that 
this difference is due to inadequate folding of the Nj subdo-
main within yeast. Alternatively, the GAL4BD fusion partner 
might block the interaction of the Ni subdomain with Hap-
46. Interestingly, neither of these subdomains Ni and N2 in-
teracted with Hip/p48 in our yeast experiments (Fig. 4). This 
is not surprising in view of the fact that hsc70 has been re-
ported to require ADP for efficient binding of Hip/p48 [25] 
but cleavage of the ATP binding domain into two separate 
portions certainly results in loss of nucleotide binding ability. 
With hsp40 we found in far-Western blots and in the two 
hybrid system that it clearly interacts with the carboxy-termi-
nal portion of hsp70 (cf. Figs. 2 and 4). This is consistent with 
the finding that the very carboxy-terminus of hsp70 is in-
volved in the interaction with HDJ-1 [27], like hsp40 a mem-
ber of the DnaJ-like protein family [4]. Our observation is also 
reminiscent of the interaction between DnaK and DnaJ pro-
teins, the prokaryotic homologs of hsp70 and hsp40, respec-
tively. Deletion of the carboxy-terminal 94 amino acids of 
DnaK abolished the recruitment of DnaJ [28]. 
A protein equivalent to human Hop/p60 [7] and termed 
RF-hsp70 (recycling factor for hsp70) has been purified 
from rabbit reticulocyte lysate [29,30]. It is thought to bind 
near the ATP binding site of hsp70 [29], i.e. within the amino-
terminal portion. By contrast, our experiments unequivocally 
establish that Hop/p60 directly interacts with the carboxy-ter-
minal domain of hsp70 rather than the ATP binding domain 
(cf. Figs. 2 and 4). Nevertheless Hop/p60 affects the chaper-
oning activity and this finding suggests interdomain commu-
nication within hsp70 molecules, as has been observed before 
[27,31,32] and is further discussed below. 
The potential roles of the hsp70/hsc70 partner proteins Hip/ 
p48 and Hop/p60 in the hsc70/ATPase reaction cycle have 
recently been discussed [2]. In essence, this cycle involves re-
peated binding and release of polypeptides to be folded with 
concomitant ATP hydrolysis and nucleotide exchange on the 
chaperone. With the data presented above, Hap-46 now also 
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needs to be taken into account as an inhibitor of hsp70/hsc70 
in protein folding reactions, although the mechanistic details 
of this inhibition still need to be elucidated. On the other 
hand, the physiological functions of Hip/p48 and Hop/p60 
are also far from being clear. Although RF-hsp70, the homo-
log of Hop/p60, has been reported to promote nucleotide ex-
change on hsp70 [29], we observed no significant enhancement 
in experiments with hsc70 and Hop/p60 (unpublished data). 
Hip/p48 has been found to stimulate the refolding of lucifer-
ase denatured by guanidinium-HCl [5] but had no effect on 
the reactivation of the same model protein after heat treat-
ment (cf. Fig. 5, column 3). Moreover Hip/p48 may be sub-
stituted by hsp40 in protein folding reactions [12]. Refolding 
of thermally damaged rather than chemically denatured pro-
teins is certainly of more relevance to what happens in intact 
cells. We suspect that Hap-46 may play a role in the decision 
on whether, upon stress conditions, misfolded proteins are 
refolded within cells or rather degraded [11,33]. Further ex-
periments are required along these lines. 
The X-ray structure of the carboxy-terminal domain of 
bacterial DnaK again shows two subdomains [34]. One of 
these, consisting of a sandwich of ß strands, binds polypep-
tides in their extended configuration, while the other is built 
up of five ce helices and may contact the ATP binding domain 
at the other end of the primary structure [34]. Because of 
homologies in sequences, it is inferred that the basic structure 
of eukaryotic hsp70s is quite similar. This then provides an 
explanation for our observation that the inhibitory effect of 
Hap-46 on protein folding can be compensated by Hop/p60 
(cf. Fig. 5) even though these hsc70 binding proteins interact 
with distinct domains (cf. Figs. 2 and 4) and do not compete 
for binding to hsc70 (cf. Fig. 3A). We suppose that by way of 
this contact between the a helical portion at the carboxy-ter-
minus of hsc70 and the ATP binding domain molecular com-
munication may occur between Hop/p60 and Hap-46. Similar 
considerations apply to Hap-46 and hsp40, which also inter-
acts with the carboxy-terminal domain of hsc70 (cf. Figs. 2 
and 4). 
The data presented here extend the view that various cel-
lular proteins cooperate with hsp70/hsc70. Also, cooperation 
between the chaperoning systems of hsp70/hsc70 and hsp90 
has recently been shown and discussed [3,35-37]. Interestingly, 
we did not obtain any evidence for the participation of hsp90 
in our protein refolding experiments when we used the hsp90 
specific inhibitor geldanamycin [20,21]. However, the refold-
ing system employed here uses a minimal amount of reticulo-
cyte lysate and hence contains a rather low concentration of 
hsp90, i.e. in the order of 75 nM. It thus appears that a 
variety of protein folding systems may exist simultaneously 
and function concomitantly. 
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